share_log

JMP Securities Initiates Coverage On Werewolf Therapeutics With Market Outperform Rating, Announces Price Target of $12

JMP Securities Initiates Coverage On Werewolf Therapeutics With Market Outperform Rating, Announces Price Target of $12

JMP證券以市場跑贏大盤的評級啓動對狼人療法的報道,宣佈目標股價爲12美元
Moomoo 24/7 ·  04/03 04:47

JMP Securities analyst Reni Benjamin initiates coverage on Werewolf Therapeutics (NASDAQ:HOWL) with a Market Outperform rating and announces Price Target of $12.

JMP證券分析師雷尼·本傑明以市場跑贏大盤的評級啓動了對狼人療法(納斯達克股票代碼:HOWL)的報道,並宣佈目標股價爲12美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論